Literature DB >> 22291902

Microarray analysis of HIV resistant female sex workers reveal a gene expression signature pattern reminiscent of a lowered immune activation state.

Elijah M Songok1, Ma Luo, Ben Liang, Paul Mclaren, Nadine Kaefer, Winnie Apidi, Genevieve Boucher, Joshua Kimani, Charles Wachihi, Rafick Sekaly, Keith Fowke, Blake T Ball, Francis A Plummer.   

Abstract

To identify novel biomarkers for HIV-1 resistance, including pathways that may be critical in anti-HIV-1 vaccine design, we carried out a gene expression analysis on blood samples obtained from HIV-1 highly exposed seronegatives (HESN) from a commercial sex worker cohort in Nairobi and compared their profiles to HIV-1 negative controls. Whole blood samples were collected from 43 HIV-1 resistant sex workers and a similar number of controls. Total RNA was extracted and hybridized to the Affymetrix HUG 133 Plus 2.0 micro arrays (Affymetrix, Santa Clara CA). Output data was analysed through ArrayAssist software (Agilent, San Jose CA). More than 2,274 probe sets were differentially expressed in the HESN as compared to the control group (fold change ≥1.3; p value ≤0.0001, FDR <0.05). Unsupervised hierarchical clustering of the differentially expressed genes readily distinguished HESNs from controls. Pathway analysis through the KEGG signaling database revealed a majority of the impacted pathways (13 of 15, 87%) had genes that were significantly down regulated. The most down expressed pathways were glycolysis/gluconeogenesis, pentose phosphate, phosphatidyl inositol, natural killer cell cytotoxicity and T-cell receptor signaling. Ribosomal protein synthesis and tight junction genes were up regulated. We infer that the hallmark of HIV-1 resistance is down regulation of genes in key signaling pathways that HIV-1 depends on for infection.

Entities:  

Mesh:

Year:  2012        PMID: 22291902      PMCID: PMC3266890          DOI: 10.1371/journal.pone.0030048

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  71 in total

Review 1.  Signaling takes a breath--new quantitative perspectives on bioenergetics and signal transduction.

Authors:  S Krauss; M D Brand; F Buttgereit
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

2.  APOBEC3G genetic variants and their association with risk of HIV infection in highly exposed Caucasians.

Authors:  Han Sang Valcke; Nicole F Bernard; Julie Bruneau; Michel Alary; Christos M Tsoukas; Michel Roger
Journal:  AIDS       Date:  2006-10-03       Impact factor: 4.177

3.  Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro.

Authors:  S Isotani; K Hara; C Tokunaga; H Inoue; J Avruch; K Yonezawa
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

4.  Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.

Authors:  P Proost; I De Meester; D Schols; S Struyf; A M Lambeir; A Wuyts; G Opdenakker; E De Clercq; S Scharpé; J Van Damme
Journal:  J Biol Chem       Date:  1998-03-27       Impact factor: 5.157

5.  Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation.

Authors:  Anna Suy; Pedro Castro; Meritxell Nomdedeu; Felipe García; Anna López; Emilio Fumero; Teresa Gallart; Lucia Lopalco; Oriol Coll; José M Gatell; Montserrat Plana
Journal:  J Infect Dis       Date:  2007-09-17       Impact factor: 5.226

6.  Selective decrease of CD26 expression in T cells from HIV-1-infected individuals.

Authors:  M V Blazquez; J A Madueño; R Gonzalez; R Jurado; W W Bachovchin; J Peña; E Muñoz
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

7.  Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection.

Authors:  Richard T Lester; Xiao-Dan Yao; T Blake Ball; Lyle R McKinnon; Rupert Kaul; Charles Wachihi; Walter Jaoko; Francis A Plummer; Kenneth L Rosenthal
Journal:  AIDS       Date:  2008-03-30       Impact factor: 4.177

8.  Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects.

Authors:  G Vanham; L Kestens; I De Meester; J Vingerhoets; G Penne; G Vanhoof; S Scharpé; H Heyligen; E Bosmans; J L Ceuppens
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-07

9.  Identification of differentially expressed proteins in the cervical mucosa of HIV-1-resistant sex workers.

Authors:  Adam Burgener; Julie Boutilier; Charles Wachihi; Joshua Kimani; Michael Carpenter; Garrett Westmacott; Keding Cheng; Terry B Ball; Francis Plummer
Journal:  J Proteome Res       Date:  2008-08-16       Impact factor: 4.466

10.  Cellular immune factors associated with mother-to-infant transmission of HIV.

Authors:  M Clerici; A V Sison; J A Berzofsky; T A Rakusan; C D Brandt; M Ellaurie; M Villa; C Colie; D J Venzon; J L Sever
Journal:  AIDS       Date:  1993-11       Impact factor: 4.177

View more
  33 in total

1.  Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection.

Authors:  Laura Pattacini; Jared M Baeten; Katherine K Thomas; Tayler R Fluharty; Pamela M Murnane; Deborah Donnell; Elizabeth Bukusi; Allan Ronald; Nelly Mugo; Jairam R Lingappa; Connie Celum; M Juliana McElrath; Jennifer M Lund
Journal:  J Acquir Immune Defic Syndr       Date:  2016-06-01       Impact factor: 3.731

2.  Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals.

Authors:  Laura Pattacini; Pamela M Murnane; Erin M Kahle; Michael J Bolton; Jeffrey J Delrow; Jairam R Lingappa; Elly Katabira; Deborah Donnell; M Juliana McElrath; Jared M Baeten; Jennifer M Lund
Journal:  AIDS Res Hum Retroviruses       Date:  2013-07-30       Impact factor: 2.205

3.  Acting locally: innate mucosal immunity in resistance to HIV-1 infection in Kenyan commercial sex workers.

Authors:  X-D Yao; R W Omange; B M Henrick; R T Lester; J Kimani; T B Ball; F A Plummer; K L Rosenthal
Journal:  Mucosal Immunol       Date:  2013-06-26       Impact factor: 7.313

4.  Pre-exposure prophylaxis differentially alters circulating and mucosal immune cell activation in herpes simplex virus type 2 seropositive women.

Authors:  Laura E Richert-Spuhler; Laura Pattacini; Margot Plews; Elizabeth Irungu; Timothy R Muwonge; Elly Katabira; Nelly Mugo; Adrienne F A Meyers; Connie Celum; Jared M Baeten; Jairam R Lingappa; Jennifer M Lund
Journal:  AIDS       Date:  2019-11-15       Impact factor: 4.177

5.  HIV-1-exposed seronegative individuals show alteration in TLR expression and pro-inflammatory cytokine production ex vivo: An innate immune quiescence status?

Authors:  Juan C Hernandez; Georges St Laurent; Silvio Urcuqui-Inchima
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

Review 6.  Mucosal correlates of protection in HIV-1-exposed sero-negative persons.

Authors:  Ruizhong Shen; Phillip D Smith
Journal:  Am J Reprod Immunol       Date:  2014-01-16       Impact factor: 3.886

Review 7.  Host-pathogen interaction in HIV infection.

Authors:  Ankita Chowdhury; Guido Silvestri
Journal:  Curr Opin Immunol       Date:  2013-07-24       Impact factor: 7.486

8.  Association between cellular immune activation, target cell frequency, and risk of human immunodeficiency virus type 1 superinfection.

Authors:  Catherine A Blish; Ozge C Dogan; Walter Jaoko; R Scott McClelland; Kishorchandra Mandaliya; Katherine Odem-Davis; Barbra A Richardson; Julie Overbaugh
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

9.  Early SIV Dissemination After Intrarectal SIVmac251 Challenge Was Associated With Proliferating Virus-Susceptible Cells in the Colorectum.

Authors:  Yongjun Sui; Eun Mi Lee; Yichuan Wang; Alison Hogg; Blake Frey; David Venzon; Ranajit Pal; Jay A Berzofsky
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-01       Impact factor: 3.731

10.  HIV-1 transgenic rats display mitochondrial abnormalities consistent with abnormal energy generation and distribution.

Authors:  Lance M Villeneuve; Phillip R Purnell; Kelly L Stauch; Shannon E Callen; Shilpa J Buch; Howard S Fox
Journal:  J Neurovirol       Date:  2016-02-03       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.